Health Tech

Hone Health Secures $228M for Longevity Platform

Hone Health's funding includes $28 million in equity as Series A financing, as well as $200 million in growth financing from General Catalyst's Customer Value Fund. 

money growth fundraise

Hone Health, a longevity platform, announced on Wednesday that it has raised $228 million in financing to support its expansion.

The direct-to-consumer company offers access to biomarker testing, physician consultations and personalized treatments, including for menopause, weight management, thyroid, heart health and sexual health. Hone Health has supported more than 200,000 patients.

“Many people, including myself, have been failed by the current healthcare system,” said Saad Alam, co-founder and CEO of Hone Health. “While people have never had more data about their own bodies, they have had little guidance on what to actually do with it. Hone Health wants to solve this problem by providing people with the highest level of insight into their metrics to help them make more informed decisions about health and longevity.”

presented by

The financing was led by MarcyPen Capital Partners, with participation from Pentland Ventures, Kinship Ventures, Hanwha, Gannet Capital, humbition, Comma Capital and ID Ventures. The funding includes $28 million in equity as Series A financing, as well as $200 million in growth financing from General Catalyst’s Customer Value Fund. 

Gwyneth Paltrow, actress and founder of wellness company Goop, is also a co-founder of Kinship Ventures and noted that wellness is a growing category of health.

“When I started goop, wellness was a niche conversation,” Paltrow said. “Today it’s one of the biggest categories in the world, and the next step is bringing real health and wellness to the masses, not just the few. Saad has built Hone to do exactly that, with serious science and at real scale. That’s why Kinship invested, and we could not be more excited about what’s ahead.”

The funding will be used to support expansion in five ways, according to the announcement:

presented by
  • Launching and scaling programs for metabolic health, PMOS, inflammation and immunity
  • Integrating diagnostic tools into longitudinal patient care, such as MRIs and gut microbiome testing
  • Improving its AI technology to help clinicians personalize care
  • Launching a physician-supervised peptide program
  • Advancing clinical trials infrastructure

In addition to the funding, Hone Health also announced the launch of Hone Black, which is a new type of membership with Hone Health that includes access to testing of more than 1,600 biomarkers; care across hormonal health, metabolic health and cognitive health; a concierge team and advanced treatments. The program has been in stealth for the last year.

“Hone Black is our most comprehensive concierge longevity membership to date, combining extensive diagnostics with ongoing care from a dedicated team of physicians responsible for a whole-body care plan,” Alam said.

He added that ultimately, Hone Health aims to build a research platform that improves health outcomes and helps people live longer.

Photo: Richard Drury, Getty Images